Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feher

Showing results (741-750 of 875) with videos related to

Pageof 88
Sort By:
Frontiers in Physiology|May 23, 2022
Refining Our Understanding of the Flow Through Coronary Artery Branches; Revisiting Murray's Law in Human Epicardial Coronary ArteriesDaniel J Taylor, Jeroen Feher, Ian Halliday, et al.
Gerontology|October 1, 2010
Increased total scavenger capacity and decreased liver fat content in rats fed dehydroepiandrosterone and its sulphate on a high-fat dietZoltan Magyar, Gabor Bekesi, Karoly Racz, et al.
Plos One|August 13, 2021
Poly(amino acid) based fibrous membranes with tuneable in vivo biodegradationKristof Molnar, Constantinos Voniatis, Daniella Feher, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 1, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods StudySimon de Lusignan, Andrew McGovern, William Hinton, et al.
The American Journal of Emergency Medicine|April 4, 2025
Automated computation of the HEART score with the GPT-4 large language modelDonald S Wright, Vimig Socrates, Thomas Huang, et al.
JACC. Cardiooncology|January 13, 2021
Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced CardiotoxicityNabil E Boutagy, Attila Feher, Daniel Pfau, et al.
The Lancet. Public Health|July 30, 2025
Hepatitis A vaccination coverage in adults with chronic liver disease in primary care in England: a retrospective cohort studyBernardo Meza-Torres, Gavin Jamie, Rashmi Wimalaratna, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
International Journal of Antimicrobial Agents|November 25, 2018
Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactamCristina De la Calle, Olga Rodríguez, Laura Morata, et al.
Journal of Clinical Medicine|December 11, 2022
Safety and Feasibility of Catheter Ablation Procedures in Patients with Bleeding DisordersMarcel Feher, Ardan M Saguner, Bettina Kirstein, et al.
Pageof 88

Showing results (741-750 of 875) with videos related to

Sort By:
Pageof 88
Frontiers in Physiology|May 23, 2022
Refining Our Understanding of the Flow Through Coronary Artery Branches; Revisiting Murray's Law in Human Epicardial Coronary ArteriesDaniel J Taylor, Jeroen Feher, Ian Halliday, et al.
Gerontology|October 1, 2010
Increased total scavenger capacity and decreased liver fat content in rats fed dehydroepiandrosterone and its sulphate on a high-fat dietZoltan Magyar, Gabor Bekesi, Karoly Racz, et al.
Plos One|August 13, 2021
Poly(amino acid) based fibrous membranes with tuneable in vivo biodegradationKristof Molnar, Constantinos Voniatis, Daniella Feher, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 1, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods StudySimon de Lusignan, Andrew McGovern, William Hinton, et al.
The American Journal of Emergency Medicine|April 4, 2025
Automated computation of the HEART score with the GPT-4 large language modelDonald S Wright, Vimig Socrates, Thomas Huang, et al.
JACC. Cardiooncology|January 13, 2021
Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced CardiotoxicityNabil E Boutagy, Attila Feher, Daniel Pfau, et al.
The Lancet. Public Health|July 30, 2025
Hepatitis A vaccination coverage in adults with chronic liver disease in primary care in England: a retrospective cohort studyBernardo Meza-Torres, Gavin Jamie, Rashmi Wimalaratna, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Combining Sodium-Glucose Co-Transporter-2 Inhibitor Plus Glucagon-Like Peptide-1 Receptor Agonist for Glucose-Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real-World Clinical Practice (CombiKid Study)William Hinton, Mark Joy, Anna K Forbes, et al.
International Journal of Antimicrobial Agents|November 25, 2018
Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactamCristina De la Calle, Olga Rodríguez, Laura Morata, et al.
Journal of Clinical Medicine|December 11, 2022
Safety and Feasibility of Catheter Ablation Procedures in Patients with Bleeding DisordersMarcel Feher, Ardan M Saguner, Bettina Kirstein, et al.
Pageof 88